Peter’s Take is a weekly opinion column. The views and opinions expressed in this column are those of the author and do not necessarily reflect the views of ARLnow.com. On April 1, ARLnow.com reported ...
Hypoparathyroidism is the most common endocrine disorder detected in patients with autoimmune polyendocrine syndrome type 1 (APS-1); however, a parathyroid-specific autoantibody has not yet been ...
Cross-sections of lungs from mice with the gene deficiency that causes APS-1, showing damaged tissue in mice not administered ruxolitinib (left) and healthy tissue in mice administered ruxolitinib ...
A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1). Researchers ...
A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1). Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results